▶ 調査レポート

世界のCD抗原がん治療市場規模・現状・予測（2021年-2027年）
• 英文タイトル：Global CD Antigen Cancer Therapy Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のCD抗原がん治療市場規模・現状・予測（2021年-2027年） / Global CD Antigen Cancer Therapy Market Size, Status and Forecast 2021-2027 / QFJ1-3982資料のイメージです。• レポートコード：QFJ1-3982
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、123ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Multi User￥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
QYResearch社発行の本調査レポートでは、CD抗原がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、皮下、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・CD抗原がん治療の市場動向
・企業の競争状況、市場シェア
・CD抗原がん治療の種類別市場規模と予測2016-2027（静脈内、皮下、その他）
・CD抗原がん治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・CD抗原がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・CD抗原がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・CD抗原がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・CD抗原がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・CD抗原がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、Celltrion、Pfizer、UCB、Roche、Merck、Johnson & Johnson、Novartis、Eli Lilly、Bayer、AstraZeneca、Spectrum Pharmaceuticals、Seattle Genetics、AryoGen Biopharma、Biogen Idec、Celltrion、Hetero Drugs）
・結論

Market Analysis and Insights: Global CD Antigen Cancer Therapy Market
The global CD Antigen Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CD Antigen Cancer Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CD Antigen Cancer Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CD Antigen Cancer Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CD Antigen Cancer Therapy market.

Global CD Antigen Cancer Therapy Scope and Market Size
CD Antigen Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CD Antigen Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intravenous
Subcutaneous
Others

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Celltrion
Pfizer
UCB
Roche
Merck
Johnson & Johnson
Novartis
Eli Lilly
Bayer
AstraZeneca
Spectrum Pharmaceuticals
Seattle Genetics
AryoGen Biopharma
Biogen Idec
Celltrion
Hetero Drugs

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD Antigen Cancer Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous
1.2.3 Subcutaneous
1.2.4 Others
1.3 Market by Application
1.3.1 Global CD Antigen Cancer Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CD Antigen Cancer Therapy Market Perspective (2016-2027)
2.2 CD Antigen Cancer Therapy Growth Trends by Regions
2.2.1 CD Antigen Cancer Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CD Antigen Cancer Therapy Historic Market Share by Regions (2016-2021)
2.2.3 CD Antigen Cancer Therapy Forecasted Market Size by Regions (2022-2027)
2.3 CD Antigen Cancer Therapy Industry Dynamic
2.3.1 CD Antigen Cancer Therapy Market Trends
2.3.2 CD Antigen Cancer Therapy Market Drivers
2.3.3 CD Antigen Cancer Therapy Market Challenges
2.3.4 CD Antigen Cancer Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CD Antigen Cancer Therapy Players by Revenue
3.1.1 Global Top CD Antigen Cancer Therapy Players by Revenue (2016-2021)
3.1.2 Global CD Antigen Cancer Therapy Revenue Market Share by Players (2016-2021)
3.2 Global CD Antigen Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CD Antigen Cancer Therapy Revenue
3.4 Global CD Antigen Cancer Therapy Market Concentration Ratio
3.4.1 Global CD Antigen Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD Antigen Cancer Therapy Revenue in 2020
3.5 CD Antigen Cancer Therapy Key Players Head office and Area Served
3.6 Key Players CD Antigen Cancer Therapy Product Solution and Service
3.7 Date of Enter into CD Antigen Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CD Antigen Cancer Therapy Breakdown Data by Type
4.1 Global CD Antigen Cancer Therapy Historic Market Size by Type (2016-2021)
4.2 Global CD Antigen Cancer Therapy Forecasted Market Size by Type (2022-2027)

5 CD Antigen Cancer Therapy Breakdown Data by Application
5.1 Global CD Antigen Cancer Therapy Historic Market Size by Application (2016-2021)
5.2 Global CD Antigen Cancer Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CD Antigen Cancer Therapy Market Size (2016-2027)
6.2 North America CD Antigen Cancer Therapy Market Size by Type
6.2.1 North America CD Antigen Cancer Therapy Market Size by Type (2016-2021)
6.2.2 North America CD Antigen Cancer Therapy Market Size by Type (2022-2027)
6.2.3 North America CD Antigen Cancer Therapy Market Size by Type (2016-2027)
6.3 North America CD Antigen Cancer Therapy Market Size by Application
6.3.1 North America CD Antigen Cancer Therapy Market Size by Application (2016-2021)
6.3.2 North America CD Antigen Cancer Therapy Market Size by Application (2022-2027)
6.3.3 North America CD Antigen Cancer Therapy Market Size by Application (2016-2027)
6.4 North America CD Antigen Cancer Therapy Market Size by Country
6.4.1 North America CD Antigen Cancer Therapy Market Size by Country (2016-2021)
6.4.2 North America CD Antigen Cancer Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe CD Antigen Cancer Therapy Market Size (2016-2027)
7.2 Europe CD Antigen Cancer Therapy Market Size by Type
7.2.1 Europe CD Antigen Cancer Therapy Market Size by Type (2016-2021)
7.2.2 Europe CD Antigen Cancer Therapy Market Size by Type (2022-2027)
7.2.3 Europe CD Antigen Cancer Therapy Market Size by Type (2016-2027)
7.3 Europe CD Antigen Cancer Therapy Market Size by Application
7.3.1 Europe CD Antigen Cancer Therapy Market Size by Application (2016-2021)
7.3.2 Europe CD Antigen Cancer Therapy Market Size by Application (2022-2027)
7.3.3 Europe CD Antigen Cancer Therapy Market Size by Application (2016-2027)
7.4 Europe CD Antigen Cancer Therapy Market Size by Country
7.4.1 Europe CD Antigen Cancer Therapy Market Size by Country (2016-2021)
7.4.2 Europe CD Antigen Cancer Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CD Antigen Cancer Therapy Market Size (2016-2027)
8.2 Asia-Pacific CD Antigen Cancer Therapy Market Size by Type
8.2.1 Asia-Pacific CD Antigen Cancer Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CD Antigen Cancer Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CD Antigen Cancer Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific CD Antigen Cancer Therapy Market Size by Application
8.3.1 Asia-Pacific CD Antigen Cancer Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CD Antigen Cancer Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CD Antigen Cancer Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific CD Antigen Cancer Therapy Market Size by Region
8.4.1 Asia-Pacific CD Antigen Cancer Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CD Antigen Cancer Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CD Antigen Cancer Therapy Market Size (2016-2027)
9.2 Latin America CD Antigen Cancer Therapy Market Size by Type
9.2.1 Latin America CD Antigen Cancer Therapy Market Size by Type (2016-2021)
9.2.2 Latin America CD Antigen Cancer Therapy Market Size by Type (2022-2027)
9.2.3 Latin America CD Antigen Cancer Therapy Market Size by Type (2016-2027)
9.3 Latin America CD Antigen Cancer Therapy Market Size by Application
9.3.1 Latin America CD Antigen Cancer Therapy Market Size by Application (2016-2021)
9.3.2 Latin America CD Antigen Cancer Therapy Market Size by Application (2022-2027)
9.3.3 Latin America CD Antigen Cancer Therapy Market Size by Application (2016-2027)
9.4 Latin America CD Antigen Cancer Therapy Market Size by Country
9.4.1 Latin America CD Antigen Cancer Therapy Market Size by Country (2016-2021)
9.4.2 Latin America CD Antigen Cancer Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CD Antigen Cancer Therapy Market Size (2016-2027)
10.2 Middle East & Africa CD Antigen Cancer Therapy Market Size by Type
10.2.1 Middle East & Africa CD Antigen Cancer Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CD Antigen Cancer Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CD Antigen Cancer Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa CD Antigen Cancer Therapy Market Size by Application
10.3.1 Middle East & Africa CD Antigen Cancer Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CD Antigen Cancer Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CD Antigen Cancer Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa CD Antigen Cancer Therapy Market Size by Country
10.4.1 Middle East & Africa CD Antigen Cancer Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CD Antigen Cancer Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline CD Antigen Cancer Therapy Introduction
11.1.4 GlaxoSmithKline Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Celltrion
11.2.1 Celltrion Company Details
11.2.2 Celltrion Business Overview
11.2.3 Celltrion CD Antigen Cancer Therapy Introduction
11.2.4 Celltrion Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.2.5 Celltrion Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer CD Antigen Cancer Therapy Introduction
11.3.4 Pfizer Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 UCB Business Overview
11.4.3 UCB CD Antigen Cancer Therapy Introduction
11.4.4 UCB Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.4.5 UCB Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche CD Antigen Cancer Therapy Introduction
11.5.4 Roche Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck CD Antigen Cancer Therapy Introduction
11.6.4 Merck Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson CD Antigen Cancer Therapy Introduction
11.7.4 Johnson & Johnson Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis CD Antigen Cancer Therapy Introduction
11.8.4 Novartis Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly CD Antigen Cancer Therapy Introduction
11.9.4 Eli Lilly Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.9.5 Eli Lilly Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer CD Antigen Cancer Therapy Introduction
11.10.4 Bayer Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca CD Antigen Cancer Therapy Introduction
11.11.4 AstraZeneca Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.11.5 AstraZeneca Recent Development
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Details
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals CD Antigen Cancer Therapy Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.12.5 Spectrum Pharmaceuticals Recent Development
11.13 Seattle Genetics
11.13.1 Seattle Genetics Company Details
11.13.2 Seattle Genetics Business Overview
11.13.3 Seattle Genetics CD Antigen Cancer Therapy Introduction
11.13.4 Seattle Genetics Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.13.5 Seattle Genetics Recent Development
11.14 AryoGen Biopharma
11.14.1 AryoGen Biopharma Company Details
11.14.2 AryoGen Biopharma Business Overview
11.14.3 AryoGen Biopharma CD Antigen Cancer Therapy Introduction
11.14.4 AryoGen Biopharma Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.14.5 AryoGen Biopharma Recent Development
11.15 Biogen Idec
11.15.1 Biogen Idec Company Details
11.15.2 Biogen Idec Business Overview
11.15.3 Biogen Idec CD Antigen Cancer Therapy Introduction
11.15.4 Biogen Idec Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.15.5 Biogen Idec Recent Development
11.16 Celltrion
11.16.1 Celltrion Company Details
11.16.2 Celltrion Business Overview
11.16.3 Celltrion CD Antigen Cancer Therapy Introduction
11.16.4 Celltrion Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.16.5 Celltrion Recent Development
11.17 Hetero Drugs
11.17.1 Hetero Drugs Company Details
11.17.2 Hetero Drugs Business Overview
11.17.3 Hetero Drugs CD Antigen Cancer Therapy Introduction
11.17.4 Hetero Drugs Revenue in CD Antigen Cancer Therapy Business (2016-2021)
11.17.5 Hetero Drugs Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CD Antigen Cancer Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous
Table 3. Key Players of Subcutaneous
Table 4. Key Players of Others
Table 5. Global CD Antigen Cancer Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global CD Antigen Cancer Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global CD Antigen Cancer Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global CD Antigen Cancer Therapy Market Share by Regions (2016-2021)
Table 9. Global CD Antigen Cancer Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global CD Antigen Cancer Therapy Market Share by Regions (2022-2027)
Table 11. CD Antigen Cancer Therapy Market Trends
Table 12. CD Antigen Cancer Therapy Market Drivers
Table 13. CD Antigen Cancer Therapy Market Challenges
Table 14. CD Antigen Cancer Therapy Market Restraints
Table 15. Global CD Antigen Cancer Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global CD Antigen Cancer Therapy Market Share by Players (2016-2021)
Table 17. Global Top CD Antigen Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD Antigen Cancer Therapy as of 2020)
Table 18. Ranking of Global Top CD Antigen Cancer Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by CD Antigen Cancer Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players CD Antigen Cancer Therapy Product Solution and Service
Table 22. Date of Enter into CD Antigen Cancer Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CD Antigen Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global CD Antigen Cancer Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global CD Antigen Cancer Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global CD Antigen Cancer Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global CD Antigen Cancer Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global CD Antigen Cancer Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global CD Antigen Cancer Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global CD Antigen Cancer Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America CD Antigen Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America CD Antigen Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America CD Antigen Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America CD Antigen Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America CD Antigen Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America CD Antigen Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe CD Antigen Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe CD Antigen Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe CD Antigen Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe CD Antigen Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe CD Antigen Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe CD Antigen Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific CD Antigen Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific CD Antigen Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific CD Antigen Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific CD Antigen Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific CD Antigen Cancer Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific CD Antigen Cancer Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America CD Antigen Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America CD Antigen Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America CD Antigen Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America CD Antigen Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America CD Antigen Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America CD Antigen Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa CD Antigen Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa CD Antigen Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa CD Antigen Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa CD Antigen Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa CD Antigen Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa CD Antigen Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline CD Antigen Cancer Therapy Product
Table 65. GlaxoSmithKline Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Celltrion Company Details
Table 68. Celltrion Business Overview
Table 69. Celltrion CD Antigen Cancer Therapy Product
Table 70. Celltrion Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 71. Celltrion Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer CD Antigen Cancer Therapy Product
Table 75. Pfizer Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. UCB Company Details
Table 78. UCB Business Overview
Table 79. UCB CD Antigen Cancer Therapy Product
Table 80. UCB Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 81. UCB Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche CD Antigen Cancer Therapy Product
Table 85. Roche Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 86. Roche Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck CD Antigen Cancer Therapy Product
Table 90. Merck Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Johnson & Johnson Company Details
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson CD Antigen Cancer Therapy Product
Table 95. Johnson & Johnson Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 96. Johnson & Johnson Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Eli Lilly Company Details
Table 102. Eli Lilly Business Overview
Table 103. Eli Lilly CD Antigen Cancer Therapy Product
Table 104. Eli Lilly Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 105. Eli Lilly Recent Development
Table 106. Bayer Company Details
Table 107. Bayer Business Overview
Table 108. Bayer CD Antigen Cancer Therapy Product
Table 109. Bayer Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 110. Bayer Recent Development
Table 111. AstraZeneca Company Details
Table 112. AstraZeneca Business Overview
Table 113. AstraZeneca CD Antigen Cancer Therapy Product
Table 114. AstraZeneca Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 115. AstraZeneca Recent Development
Table 116. Spectrum Pharmaceuticals Company Details
Table 117. Spectrum Pharmaceuticals Business Overview
Table 118. Spectrum Pharmaceuticals CD Antigen Cancer Therapy Product
Table 119. Spectrum Pharmaceuticals Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 120. Spectrum Pharmaceuticals Recent Development
Table 121. Seattle Genetics Company Details
Table 122. Seattle Genetics Business Overview
Table 123. Seattle Genetics CD Antigen Cancer Therapy Product
Table 124. Seattle Genetics Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 125. Seattle Genetics Recent Development
Table 126. AryoGen Biopharma Company Details
Table 127. AryoGen Biopharma Business Overview
Table 128. AryoGen Biopharma CD Antigen Cancer Therapy Product
Table 129. AryoGen Biopharma Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 130. AryoGen Biopharma Recent Development
Table 131. Biogen Idec Company Details
Table 132. Biogen Idec Business Overview
Table 133. Biogen Idec CD Antigen Cancer Therapy Product
Table 134. Biogen Idec Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 135. Biogen Idec Recent Development
Table 136. Celltrion Company Details
Table 137. Celltrion Business Overview
Table 138. Celltrion CD Antigen Cancer Therapy Product
Table 139. Celltrion Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 140. Celltrion Recent Development
Table 141. Hetero Drugs Company Details
Table 142. Hetero Drugs Business Overview
Table 143. Hetero Drugs CD Antigen Cancer Therapy Product
Table 144. Hetero Drugs Revenue in CD Antigen Cancer Therapy Business (2016-2021) & (US$ Million)
Table 145. Hetero Drugs Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD Antigen Cancer Therapy Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Features
Figure 3. Subcutaneous Features
Figure 4. Others Features
Figure 5. Global CD Antigen Cancer Therapy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. CD Antigen Cancer Therapy Report Years Considered
Figure 10. Global CD Antigen Cancer Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global CD Antigen Cancer Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global CD Antigen Cancer Therapy Market Share by Regions: 2020 VS 2027
Figure 13. Global CD Antigen Cancer Therapy Market Share by Regions (2022-2027)
Figure 14. Global CD Antigen Cancer Therapy Market Share by Players in 2020
Figure 15. Global Top CD Antigen Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD Antigen Cancer Therapy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by CD Antigen Cancer Therapy Revenue in 2020
Figure 17. Global CD Antigen Cancer Therapy Revenue Market Share by Type (2016-2021)
Figure 18. Global CD Antigen Cancer Therapy Revenue Market Share by Type (2022-2027)
Figure 19. North America CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America CD Antigen Cancer Therapy Market Share by Type (2016-2027)
Figure 21. North America CD Antigen Cancer Therapy Market Share by Application (2016-2027)
Figure 22. North America CD Antigen Cancer Therapy Market Share by Country (2016-2027)
Figure 23. United States CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe CD Antigen Cancer Therapy Market Share by Type (2016-2027)
Figure 27. Europe CD Antigen Cancer Therapy Market Share by Application (2016-2027)
Figure 28. Europe CD Antigen Cancer Therapy Market Share by Country (2016-2027)
Figure 29. Germany CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific CD Antigen Cancer Therapy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific CD Antigen Cancer Therapy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific CD Antigen Cancer Therapy Market Share by Region (2016-2027)
Figure 39. China CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America CD Antigen Cancer Therapy Market Share by Type (2016-2027)
Figure 47. Latin America CD Antigen Cancer Therapy Market Share by Application (2016-2027)
Figure 48. Latin America CD Antigen Cancer Therapy Market Share by Country (2016-2027)
Figure 49. Mexico CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa CD Antigen Cancer Therapy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa CD Antigen Cancer Therapy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa CD Antigen Cancer Therapy Market Share by Country (2016-2027)
Figure 55. Turkey CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE CD Antigen Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. GlaxoSmithKline Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 59. Celltrion Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 61. UCB Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 69. Spectrum Pharmaceuticals Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 70. Seattle Genetics Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 71. AryoGen Biopharma Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 72. Biogen Idec Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 73. Celltrion Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 74. Hetero Drugs Revenue Growth Rate in CD Antigen Cancer Therapy Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

以下、関連資料のご紹介
  • 世界のがん抗原市場規模・現状・予測（2021年-2027年）
    Global Cancer Antigen Market Size, Status and Forecast 2021-2027
    QFJ1-3952 2021年6月 98Pages
    QYResearch社発行の本調査レポートでは、がん抗原の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（がん抗原125、がん抗原15-3、がん抗原27-29、がん抗原19-9、その他）、用途別市場規模（病院、診断センター、外来外科センター、その他）...
  • 世界のがん点滴療法市場規模・現状・予測（2021年-2027年）
    Global Cancer Infusion Therapy Market Size, Status and Forecast 2021-2027
    QFJ1-3956 2021年6月 99Pages
    QYResearch社発行の本調査レポートでは、がん点滴療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬局、在宅医療機関、その他）、用途別市場規模（がん、慢性疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...
  • 世界の肺がん治療市場規模・現状・予測（2021年-2027年）
    Global Lung Cancer Therapy Market Size, Status and Forecast 2021-2027
    QFJ1-4445 2021年6月 109Pages
    QYResearch社発行の本調査レポートでは、肺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、標的療法、免疫療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...
  • 世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年）
    Global Cancer Hormone Therapy Drugs Market Size, Status and Forecast 2021-2027
    QFJ1-3955 2021年6月 109Pages
    QYResearch社発行の本調査レポートでは、がんホルモン療法剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他）、用途別市場規模（乳がん、前立腺がん）、主要地域...
  • 世界の遺伝子検出用個別化癌治療市場規模・現状・予測（2021年-2027年）
    Global Gene Detection for Individualized Cancer Therapy Market Size, Status and Forecast 2021-2027
    QFJ1-4246 2021年6月 98Pages
    QYResearch社発行の本調査レポートでは、遺伝子検出用個別化癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、症状発生前検査）、用途別市場規模（病院、クリニック、診断センタ...
  • 世界の前立腺特異抗原（PSA）血液ベースバイオマーカー市場規模・現状・予測（2021年-2027年）
    Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size, Status and Forecast 2021-2027
    QFJ1-4773 2021年6月 99Pages
    QYResearch社発行の本調査レポートでは、前立腺特異抗原（PSA）血液ベースバイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スクリーニングバイオマーカー、診断バイオマーカー）、用途別市場規模（診断、創薬、個別化医療、その他）、主...
  • 世界の腎臓癌治療市場規模・現状・予測（2021年-2027年）
    Global Kidney Cancer Therapy Market Size, Status and Forecast 2021-2027
    QFJ1-5821 2021年6月 118Pages
    QYResearch社発行の本調査レポートでは、腎臓癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、mTOR阻害剤、キナーゼ阻害剤、その他）、用途別市場規模（腎細胞癌（RCC）、移行上皮癌（TCC））、主要地域別市場規模（...
  • 世界の癌胎児性抗原関連細胞接着分子5市場規模・現状・予測（2021年-2027年）
    Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, Status and Forecast 2021-2027
    QFJ1-5646 2021年6月 97Pages
    QYResearch社発行の本調査レポートでは、癌胎児性抗原関連細胞接着分子5の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ETBX-011、Vbx-016、OSE-2101、GI-6207、その他）、用途別市場規模（転移性乳がん、転移性膵臓がん...
  • 世界のB細胞成熟抗原（BCMA）標的療法市場規模・現状・予測（2021年-2027年）
    Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2021-2027
    QFJ1-3893 2021年6月 109Pages
    QYResearch社発行の本調査レポートでは、B細胞成熟抗原（BCMA）標的療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（二重特異性抗体、抗体薬物複合体、キメラ抗原受容体T細胞）、用途別市場規模（肝臓がん、呼吸器がん、脳腫瘍、その他）、主要...
  • 世界のマイコプラズマプレート抗原市場規模・現状・予測（2021年-2027年）
    Global Mycoplasma Plate Antigen Market Size, Status and Forecast 2021-2027
    QFJ1-4540 2021年6月 100Pages
    QYResearch社発行の本調査レポートでは、マイコプラズマプレート抗原の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プレート凝集試験製品、確認試験試薬）、用途別市場規模（医薬品開発、感染症治療、動物医療研究、その他）、主要地域別市場規模（北米...
  • CD抗原がん療法のグローバル市場調査 2019年CD抗原がん療法のグローバル市場調査 2019年 The global CD Antigen Cancer Therapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on CD Antigen Cancer Therapy volume and value at global level, regional level and company level. From a global persp…
  • 世界のがん抗原市場規模・現状・予測（2021年-2027年）世界のがん抗原市場規模・現状・予測（2021年-2027年） Cancer antigens are certain types of proteins secreted into the bloodstream and can be measured in both cancers and non-cancerous conditions. Cancer antigens are the tumour markers produced by cancer cells and other cells of the body which provides information about cancer. Market Analysis and Insig…
  • 世界の肺がん治療市場規模・現状・予測（2021年-2027年）世界の肺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapy Market The global Lung Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
  • 世界のがん点滴療法市場規模・現状・予測（2021年-2027年）世界のがん点滴療法市場規模・現状・予測（2021年-2027年） Cancer treatments often require infusion treatments, like chemotherapy.  Market Analysis and Insights: Global Cancer Infusion Therapy Market The global Cancer Infusion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. Wi…
  • 世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年）世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Market Analysis and Insights: Global Cancer H…